Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Non-Current Assets (2009 - 2026)

Evotec SE's (EVO) quarterly Non-Current Assets came in at $982.3 million in Q2 2026, down 27.91% year-over-year from $1.4 billion in Q2 2025, and down 9.64% quarter-over-quarter from $1.1 billion in Q1 2026.

Analysis

Evotec SE (EVO) Non-Current Assets (2009 - 2026) Analysis & Trends

Evotec SE has disclosed Non-Current Assets across 9 years of filings, most recently posting $982.3 million for Q2 2026.

  • In Q2 2026, Non-Current Assets fell 27.91% year-over-year to $982.3 million; the TTM figure through Jun 2026 stood at $982.3 million (down 27.91% YoY), while the FY2025 annual figure was $1.1 billion, down 19.33% from the prior year.
  • Non-Current Assets came in at $982.3 million for Q2 2026 at Evotec SE, down from $1.1 billion in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $1.5 billion in Q1 2024 to a low of $982.3 million in Q2 2026.
  • Average Non-Current Assets over 5 years is $1.3 billion, with a median of $1.3 billion recorded in 2022.
  • Year-over-year, Non-Current Assets climbed 20.23% in 2023 and dropped 27.91% in 2026.
  • Over 5 years, Non-Current Assets stood at $1.2 billion in 2022, then advanced by 20.23% to $1.5 billion in 2023, then decreased by 9.42% to $1.3 billion in 2024, then fell by 15.81% to $1.1 billion in 2025, then retreated by 11.27% to $982.3 million in 2026.
  • Per Business Quant data, the three most recent Non-Current Assets figures were $982.3 million in Q2 2026, $1.1 billion in Q1 2026, and $1.1 billion in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 23.66 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 1.01 Bn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 6.00 Bn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 12.65 Bn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 1.79 Bn
6 Evotec SE 642.83 Mn 216.96 Mn - 982.30 Mn
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 657.51 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 7.77 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 3.76 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn - 621,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 982.30 Mn
Mar 31, 2026 1.09 Bn
Dec 31, 2025 1.11 Bn
Sep 30, 2025 1.15 Bn
Jun 30, 2025 1.36 Bn
Mar 31, 2025 1.28 Bn
Dec 31, 2024 1.31 Bn
Sep 30, 2024 1.42 Bn
Mar 31, 2024 1.50 Bn
Dec 31, 2023 1.45 Bn
Jun 30, 2023 1.39 Bn
Dec 31, 2022 1.21 Bn
Sep 30, 2022 1.18 Bn
Mar 31, 2022 1.26 Bn
Dec 31, 2021 1.30 Bn
Sep 30, 2021 1.34 Bn
Dec 31, 2020 958.00 Mn
Sep 30, 2010 125.72 Mn
Jun 30, 2010 90.92 Mn
Mar 31, 2010 108,579.25